Objective: To critically review the literature on vardenafil in the treatment of erectile dysfunction while integrating the clinical findings with the personal experience of the authors. Methods: Analysis of published full-length papers that were identified through Medline search from January 2000 through May 2004. Abstracts published in peer-reviewed journals from the same period were also considered. Results: Efficacy, tolerability and safety, as reported in the peer-reviewed literature compares well with the authors' personal experience. Authors' personal observations include discussions on potency, selectivity, selection of initial dose, counselling for patients characteristically considered difficult-to-treat (diabetes, prostatectomy, ...
OBJECTIVE — This study evaluated the efficacy and safety of vardenafil treatment for erectile dysfun...
The immediate objective of phosphodiesterase type 5 (PDE5) inhibitor treatment is to restore the abi...
Background: A rapid onset of action for phosphodiesterase type 5 inhibitors (PDE5is) emerged to be o...
Objective: To critically review the literature on vardenafil in the treatment of erectile dysfunctio...
Antonio Martín Morales1, Vincenzo Mirone2, John Dean3, Pierre Costa41Department of Urology, H...
To evaluate the efficacy and safety of vardenafil on men with erectile dysfunction (ED) of various e...
Introduction: Erectile dysfunction (ED) is a common male sexual disorder among men.Many governing bo...
SUMMARY Vardenafil is a highly selective phosphodiesterase-5 (PDE-5) inhibitor approved for the trea...
Background. Vardenafil (Levitra\uae) is a potent and selective phosphodiesterase 5 (PDE5) inhibitor ...
Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitordeveloped for the treatment of erectile dys...
Aim. To evaluate the efficacy, safety, and tolerability of a flexible-dose regimen of vardenafil in ...
We assessed the safety, efficacy and patient acceptability of vardenafil (Levitra®, Bayer HealthCare...
We read with great interest the article by Francesco Montorsi et al reviewing the literature on vard...
AIM: To evaluate the efficacy, safety, and tolerability of a flexible-dose regimen of vardenafil...
Erectile dysfunction (ED) is a common medical condition that affects the sexual life of millions of ...
OBJECTIVE — This study evaluated the efficacy and safety of vardenafil treatment for erectile dysfun...
The immediate objective of phosphodiesterase type 5 (PDE5) inhibitor treatment is to restore the abi...
Background: A rapid onset of action for phosphodiesterase type 5 inhibitors (PDE5is) emerged to be o...
Objective: To critically review the literature on vardenafil in the treatment of erectile dysfunctio...
Antonio Martín Morales1, Vincenzo Mirone2, John Dean3, Pierre Costa41Department of Urology, H...
To evaluate the efficacy and safety of vardenafil on men with erectile dysfunction (ED) of various e...
Introduction: Erectile dysfunction (ED) is a common male sexual disorder among men.Many governing bo...
SUMMARY Vardenafil is a highly selective phosphodiesterase-5 (PDE-5) inhibitor approved for the trea...
Background. Vardenafil (Levitra\uae) is a potent and selective phosphodiesterase 5 (PDE5) inhibitor ...
Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitordeveloped for the treatment of erectile dys...
Aim. To evaluate the efficacy, safety, and tolerability of a flexible-dose regimen of vardenafil in ...
We assessed the safety, efficacy and patient acceptability of vardenafil (Levitra®, Bayer HealthCare...
We read with great interest the article by Francesco Montorsi et al reviewing the literature on vard...
AIM: To evaluate the efficacy, safety, and tolerability of a flexible-dose regimen of vardenafil...
Erectile dysfunction (ED) is a common medical condition that affects the sexual life of millions of ...
OBJECTIVE — This study evaluated the efficacy and safety of vardenafil treatment for erectile dysfun...
The immediate objective of phosphodiesterase type 5 (PDE5) inhibitor treatment is to restore the abi...
Background: A rapid onset of action for phosphodiesterase type 5 inhibitors (PDE5is) emerged to be o...